12:00 AM
May 21, 2007
 |  BC Week In Review  |  Company News  |  Deals

Biovel Life Sciences Pte. Ltd., Dow Chemical deal

Biovel received non-exclusive rights to use DOW subsidiary Dowpharma's Pseudomonas-based Pfenex Expression Technology to manufacture...

Read the full 53 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >